Nathalia Perleberg Bachettini1, Renata Moraes Bielemann2,3,4, Thiago Gonzalez Barbosa-Silva4,5, Ana Maria Baptista Menezes4, Elaine Tomasi4, Maria Cristina Gonzalez6,2,4. 1. Post-Graduate Program in Health and Behavior, Catholic University of Pelotas, Pelotas, Brazil. nathperleberg@hotmail.com. 2. Post-Graduate Program in Nutrition and Foods, Federal University of Pelotas, Pelotas, Brazil. 3. Post-Graduate Program in Physical Education, Federal University of Pelotas, Pelotas, Brazil. 4. Post-Graduate Program in Epidemiology, Federal University of Pelotas, Pelotas, Brazil. 5. Department of Surgery, School of Medicine, Federal University of Pelotas, Pelotas, Brazil. 6. Post-Graduate Program in Health and Behavior, Catholic University of Pelotas, Pelotas, Brazil.
Abstract
BACKGROUND/ OBJECTIVES: The definition of sarcopenia remains a matter of discussion and there is no globally accepted consensus for its diagnosis. The aim of this study was to assess the effect of sarcopenia diagnostic components on mortality, as well as to compare the associations between sarcopenia diagnosed via the 2010 and 2018 Consensuses of the European Working Group on Sarcopenia in Older People (EWGSOP) and mortality. METHODS: Prospective cohort study involving noninstitutionalized older adults aged ≥ 60 years. For the diagnosis of sarcopenia, the definitions proposed by the 2010 (EWGSOP) and 2018 (EWGSOP2) Consensuses were used. The diagnostic components corresponded to muscle mass, muscular strength, and physical performance. The associations of sarcopenia and its components with mortality were investigated using Cox proportional hazard regression models. RESULTS: The sample consisted of 1291 older adults. After an average of 2.6 years of follow-up, 88 (6.8%) participants had died. The diagnosis of severe sarcopenia by both Consensuses was associated with an increased risk of mortality. Severe sarcopenia was associated with an increased risk of death compared with that in people without sarcopenia when using EWGSOP (hazard ratio (HR) 3.15, 95% confidence interval (CI) 1.44-6.90) and EWGSOP2 (HR 4.11, 95% CI 1.88-9.00). Older adults with decreased gait speed had a 76% higher risk of dying (p = 0.033). There was no statistically significant association between the other sarcopenia components and mortality risk. CONCLUSIONS: Older adults with severe sarcopenia and those with changes in physical performance had an increased risk of death in the short term.
BACKGROUND/ OBJECTIVES: The definition of sarcopenia remains a matter of discussion and there is no globally accepted consensus for its diagnosis. The aim of this study was to assess the effect of sarcopenia diagnostic components on mortality, as well as to compare the associations between sarcopenia diagnosed via the 2010 and 2018 Consensuses of the European Working Group on Sarcopenia in Older People (EWGSOP) and mortality. METHODS: Prospective cohort study involving noninstitutionalized older adults aged ≥ 60 years. For the diagnosis of sarcopenia, the definitions proposed by the 2010 (EWGSOP) and 2018 (EWGSOP2) Consensuses were used. The diagnostic components corresponded to muscle mass, muscular strength, and physical performance. The associations of sarcopenia and its components with mortality were investigated using Cox proportional hazard regression models. RESULTS: The sample consisted of 1291 older adults. After an average of 2.6 years of follow-up, 88 (6.8%) participants had died. The diagnosis of severe sarcopenia by both Consensuses was associated with an increased risk of mortality. Severe sarcopenia was associated with an increased risk of death compared with that in people without sarcopenia when using EWGSOP (hazard ratio (HR) 3.15, 95% confidence interval (CI) 1.44-6.90) and EWGSOP2 (HR 4.11, 95% CI 1.88-9.00). Older adults with decreased gait speed had a 76% higher risk of dying (p = 0.033). There was no statistically significant association between the other sarcopenia components and mortality risk. CONCLUSIONS: Older adults with severe sarcopenia and those with changes in physical performance had an increased risk of death in the short term.
Authors: R N Baumgartner; K M Koehler; D Gallagher; L Romero; S B Heymsfield; R R Ross; P J Garry; R D Lindeman Journal: Am J Epidemiol Date: 1998-04-15 Impact factor: 4.897
Authors: Marc Sim; Richard L Prince; David Scott; Robin M Daly; Gustavo Duque; Charles A Inderjeeth; Kun Zhu; Richard J Woodman; Jonathan M Hodgson; Joshua R Lewis Journal: J Am Med Dir Assoc Date: 2018-12-06 Impact factor: 4.669
Authors: Médéa Locquet; Charlotte Beaudart; Manon Hajaoui; Jean Petermans; Jean-Yves Reginster; Olivier Bruyère Journal: J Am Med Dir Assoc Date: 2018-07-19 Impact factor: 4.669
Authors: Erick P de Oliveira; Laura Cristina Jardim Porto; Lara Vilar Fernandes; Alexandre Elias Gomes Paiva; Ana Clara Borges Silva; Isabela Coelho de Castro; Andrezza Fernanda Santiago Journal: Aging Clin Exp Res Date: 2021-08-16 Impact factor: 3.636
Authors: Rebecca Knowles; Jennifer Carter; Susan A Jebb; Derrick Bennett; Sarah Lewington; Carmen Piernas Journal: J Am Heart Assoc Date: 2021-04-19 Impact factor: 5.501
Authors: Rafael Moreno-Gonzalez; Xavier Corbella; Francesco Mattace-Raso; Lisanne Tap; Cornel Sieber; Ellen Freiberger; Tomasz Kostka; Agnieszka Guligowska; Itshak Melzer; Yehudit Melzer; Axel C Carlsson; Johan Ärnlöv; Regina Roller-Wirnsberger; Gerhard Wirnsberger; Pedro Gil; Sara Lainez Martinez; Paolo Fabbietti; Andrea Corsonello; Fabrizia Lattanzio; Francesc Formiga Journal: BMC Geriatr Date: 2020-10-02 Impact factor: 3.921